#COVID-19

  • COVID-19 can have long-term impacts on the brain, shows study

    Researchers have found that subjects infected with the SARS-CoV-2 virus displayed signs of severe brain inflammation and injury consistent with a reduction in blood or oxygen flow into the brain, neuron damage and small areas of bleeding.

  • COVID-19 crisis deepened gender divides at work and home

    Findings from Eurofound’s latest research report; COVID-19 pandemic and the gender divide at work and home, highlight how traditional gender divides continue to translate into gender gaps in the labour market and areas including working conditions, poverty, total working time and work–life conflict. The report also underlines how the COVID-19 crisis deepened these divides, pointing to the critical role of care services in supporting women’s labour market participation, financial security and overall well-being.

  • Covid-19 global health emergency over: WHO

    The World Health Organisation (WHO) has announced that Covid-19 pandemic is over as a global health emergency.

    Dr Tedros Adhanom Ghebreyesus, Director-General of WHO, made the announcement while addressing a media briefing on Covid-19 and global health issues.

  • COVID-19 increases risk of type 2 diabetes, reveals study

    According to a study, people who have had COVID-19 are at increased risk of developing type 2 diabetes.

    The study was published in the journal, 'Diabetologia'.

  • COVID-19 infection can be detected in breath tests: Study

    According to a new study, traces of the SARS-CoV-2 coronavirus that causes COVID-19 can be detected in microscopically small fluid droplets exhaled during a very short time span.

    Researchers from the University of Gothenburg found that aerosol particles with the ribonucleic acid (RNA) virus can be found early in the course of COVID-19.

  • COVID-19 infection raises diabetes risk: Research

    Researchers at Cedars-Smidt Sinai's Heart Institute have confirmed that persons who have had COVID-19 have a higher risk of developing new-onset diabetes, which is the leading cause of cardiovascular disease.

    "Our results verify that the risk of developing Type 2 diabetes after a COVID-19 infection was not just an early observation but, in fact, a real risk that has, unfortunately, persisted through the Omicron era," said Alan Kwan, MD, first and corresponding author of the study and a cardiovascular physician in the Smidt Heart Institute at Cedars-Sinai.

  • COVID-19 leads to cognitive, behavioural problems in patients, a study presents

    COVID-19 patients suffer from cognitive and behavioural problems two months after being discharged from hospital, a new study presented at the 7th Congress of the European Academy of Neurology (EAN) has found.

    Issues with memory, spatial awareness and information processing problems were identified as possible overhangs from the virus in post-COVID-19 patients who were followed up within eight weeks.

  • COVID-19 pandemic can end in 2022 if international community takes comprehensive measures: WHO chief

    The international community can put an end to the coronavirus pandemic in 2022 if it takes comprehensive measures, Director-General of the World Health Organization (WHO) Tedros Adhanom Ghebreyesus said on Monday.

  • Covid-19 patients who suffer from loss of smell show different activities in brain: Study

    A study has found that people living with long Covid who suffer from loss of smell show different patterns of activity in certain regions of the brain. The study was published in the journal, 'EClinicalMedicine'.

    The research used MRI scanning to compare the brain activity of people with long Covid who lost their sense of smell, those whose smell had returned to normal after Covid infection, and people who had never tested positive for Covid-19.

  • COVID-19 survivors have increased mental health risks up to a year later: Study

    As the COVID-19 pandemic entered into its third year, countless people have undergone varying degrees of uncertainty, isolation and mental health challenges. Many are still severely affected by mental health issues. New research has revealed that those who have had COVID-19 had a significantly higher chance of experiencing mental health problems.

  • COVID-19 vaccination provides significant protection against reinfection: Study

    According to a study, individuals who have already been infected with SARS-CoV-2, the virus that causes COVID-19, still benefit from a vaccination as well, with 60% to 94% protection against reinfection, depending on the variation.

    A new study led by Katrine Finderup Nielsen at Statens Serum Institut, Denmark, reports these findings in the open-access journal PLOS Medicine.

  • COVID-19 vaccinations reduce risk of reinfection by 50 per cent

    When compared to those who have not been vaccinated, those who have recovered from a coronavirus infection have a halved risk of becoming infected a second time or contracting COVID-19 again with severe symptoms.

    These findings were revealed in an analysis published in the journal Frontiers in Medicine, which is coordinated by Lamberto Manzoli, medical epidemiologist as well as Director of the School of Public Health and Hygiene of the University of Bologna.

  • COVID-19 vaccine developed by China's CanSino to continue advancing phase-3 trials: report

    China's CanSino Biologics Inc. has got green light to continue phase-3 trials of its COVID-19 vaccine with the support of findings of an independent data monitoring committee, said recent media reports.

    The independent committee "found the drugmaker's COVID-19 vaccine met its pre-specified primary safety and efficacy targets under an interim analysis of phase-3 trial data," Reuters cited the biopharmaceutical company to report on Monday.

  • COVID-19 vaccine hoarding will prolong pandemic, warns WHO amid Omicron spread

    Amid the ongoing spread of Omicron variant around the world, a UN health agency panel on Thursday said that early laboratory data on the effectiveness of existing vaccines against the new COVID-19 variant is useful, but it is still unclear how effective these will be in treating severely sick patients.

  • COVID-19 vaccines don't affect fertility, study asserts

    A recent study has quashed rumours that COVID-19 vaccination leads to infertility.

    The study published in the 'American Journal of Epidemiology' asserts that COVID-19 vaccination does not appear to affect fertility.

  • COVID-19 will not be the last pandemic humanity will face, warns UN chief

    United Nations chief Antonio Guterres on Monday warned that the COVID-19 pandemic is not the last of its kind and that people should take measures to prevent such crises in the future.

  • COVID-19: Health worker death toll rises to at least 17,000 as organizations call for rapid vaccine rollout

    At least 17,000 health workers have died from COVID-19 over the last year, said Amnesty International, Public Services International (PSI) and UNI Global Union in a new analysis, as the organizations called for urgent action to speed up the vaccination of millions of frontline health workers around the world. 

  • COVID-19: More people are opting for self-test kits

    With the rising sale of self-testing kits in, private labs are witnessing lesser people approaching them for RT-PCR tests.

    According to private laboratory owners, there has been a rampant increase in the sale of self-testing kits, resulting in lesser people coming to labs for RT-PCR testing.

  • COVID-19: Study finds out two metres distancing not enough without masks

    According to researchers from Quebec, Illinois, and Texas, to prevent the spread of COVID-19 indoors, the two meters physical distancing guideline is not enough without masks.

  • COVID: South Africa's Health Minister unhappy with international reaction to Omicron strain

    South African Health Minister Joe Phaahla told Sputnik on Sunday that he is unhappy with the travel restrictions that many nations imposed on his country and its neighbors after the emergence of the new Omicron coronavirus strain.

Partners